Literature DB >> 25448411

Tumour progression and cancer-induced pain: a role for protease-activated receptor-2?

Pamuditha K Kularathna1, Charles N Pagel1, Eleanor J Mackie2.   

Abstract

The role of proteases in modifying the microenvironment of tumour cells has long been recognised. With the discovery of the protease-activated receptor family of G protein-coupled receptors a mechanism for cells to sense and respond directly to proteases in their microenvironment was revealed. Many early studies described the roles of protease-activated receptors in the cellular events that occur during blood coagulation and inflammation. More recently, studies have begun to focus on the roles of protease-activated receptors in the establishment, progression and metastasis of a variety of tumours. This review will focus on the expression of protease-activated receptor-2 and its activators by normal and neoplastic tissues, and describe current evidence that activation of protease-activated receptor-2 is an important event at multiple stages of tumour progression and in pain associated with cancer.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Cancer; G protein-coupled receptor; Protease-activated receptor-2; Serine protease

Mesh:

Substances:

Year:  2014        PMID: 25448411     DOI: 10.1016/j.biocel.2014.10.026

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  4 in total

1.  Inhibitors of the PAR-2 Signaling Pathway May Treat Pain and Inflammation.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2015-04-15       Impact factor: 4.345

Review 2.  Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression.

Authors:  Nisha R Pawar; Marguerite S Buzza; Toni M Antalis
Journal:  Cancer Res       Date:  2019-01-04       Impact factor: 12.701

3.  PAR-2 promotes cell proliferation, migration, and invasion through activating PI3K/AKT signaling pathway in oral squamous cell carcinoma.

Authors:  Kai-Liang Tang; Han-Ying Tang; Yi Du; Tian Tian; Shi-Jiang Xiong
Journal:  Biosci Rep       Date:  2019-07-05       Impact factor: 3.840

4.  Silencing PRSS1 suppresses the growth and proliferation of gastric carcinoma cells via the ERK pathway.

Authors:  Dongmei Ye; Yuxuan Li; Heliang Zhang; Zhiwei Zhou; Yujie Tang; Peng Wu; Qiang Zhao; Zhiwei Zhang
Journal:  Int J Biol Sci       Date:  2021-03-01       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.